Grieco, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 10.827
EU - Europa 8.574
AS - Asia 7.957
SA - Sud America 1.594
AF - Africa 185
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 29
Totale 29.203
Nazione #
US - Stati Uniti d'America 10.568
SG - Singapore 3.649
DE - Germania 3.213
CN - Cina 1.919
SE - Svezia 1.379
BR - Brasile 1.314
IT - Italia 906
VN - Vietnam 728
UA - Ucraina 714
FR - Francia 607
GB - Regno Unito 401
IE - Irlanda 390
FI - Finlandia 278
ID - Indonesia 266
IN - India 265
RU - Federazione Russa 218
JP - Giappone 204
TR - Turchia 203
HK - Hong Kong 161
BD - Bangladesh 154
CA - Canada 126
AR - Argentina 116
PL - Polonia 114
IQ - Iraq 84
MX - Messico 57
NL - Olanda 54
AT - Austria 52
ZA - Sudafrica 48
BE - Belgio 46
ES - Italia 46
EC - Ecuador 38
KR - Corea 35
PK - Pakistan 31
SA - Arabia Saudita 30
AU - Australia 29
IR - Iran 29
CO - Colombia 27
MA - Marocco 27
VE - Venezuela 26
UZ - Uzbekistan 25
AE - Emirati Arabi Uniti 22
EU - Europa 22
PH - Filippine 22
CL - Cile 20
JO - Giordania 20
KE - Kenya 20
RO - Romania 20
EG - Egitto 18
PE - Perù 17
PT - Portogallo 17
PY - Paraguay 16
CH - Svizzera 15
CZ - Repubblica Ceca 15
DZ - Algeria 15
LT - Lituania 14
CI - Costa d'Avorio 13
JM - Giamaica 13
PA - Panama 13
IL - Israele 12
TT - Trinidad e Tobago 12
MY - Malesia 11
TN - Tunisia 11
AZ - Azerbaigian 10
BO - Bolivia 10
AL - Albania 9
DK - Danimarca 9
HU - Ungheria 8
CR - Costa Rica 7
KG - Kirghizistan 7
NG - Nigeria 7
NP - Nepal 7
OM - Oman 7
SV - El Salvador 7
TH - Thailandia 7
UY - Uruguay 7
GR - Grecia 6
LK - Sri Lanka 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
BZ - Belize 5
ET - Etiopia 5
KW - Kuwait 5
KZ - Kazakistan 5
LB - Libano 5
MK - Macedonia 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GE - Georgia 4
MD - Moldavia 4
NI - Nicaragua 4
SI - Slovenia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CY - Cipro 3
GT - Guatemala 3
HN - Honduras 3
IS - Islanda 3
KH - Cambogia 3
Totale 29.143
Città #
Singapore 1.909
Chandler 1.366
Ashburn 1.099
San Jose 1.063
Jacksonville 411
Dublin 387
Beijing 366
San Mateo 334
New York 276
Ho Chi Minh City 258
Frankfurt am Main 250
Nanjing 239
Jakarta 238
Ann Arbor 223
Los Angeles 222
Lauterbourg 209
Dallas 197
Wilmington 195
Boston 190
Tokyo 184
Nürnberg 180
Houston 168
Hefei 166
Hanoi 158
Munich 158
Izmir 152
Cattolica 151
Milan 151
Rome 147
Dearborn 139
Hong Kong 138
Princeton 125
São Paulo 124
Woodbridge 119
Moscow 117
The Dalles 109
Chicago 103
Marseille 101
Nanchang 99
Helsinki 95
Boardman 89
Buffalo 82
Seattle 79
Santa Clara 77
Redwood City 68
Lawrence 66
Redmond 63
Fairfield 57
Tianjin 57
Council Bluffs 55
Hebei 55
Kraków 55
Tukwila 53
London 50
Mountain View 47
Paris 46
Bremen 45
Brooklyn 45
Brussels 45
Shenyang 45
Rio de Janeiro 43
Kunming 42
Atlanta 41
Kent 39
University Park 39
Da Nang 38
Orem 38
Zhengzhou 38
Guangzhou 37
Jiaxing 37
Warsaw 37
Hangzhou 36
Norwalk 36
Changsha 35
Augusta 34
Baghdad 34
Nuremberg 34
Phoenix 34
Montreal 32
Seoul 32
Turku 32
Denver 31
Haiphong 31
San Francisco 31
Toronto 31
Washington 31
Belo Horizonte 30
Fremont 28
Dhaka 27
Düsseldorf 27
Jinan 27
Poplar 26
St Louis 26
Amsterdam 24
Pune 24
Cambridge 23
Shanghai 23
Stockholm 23
Tashkent 23
Bexley 22
Totale 14.771
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 349
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 332
A phase II study of sunitinib in advanced hepatocellular carcinoma 280
13C-methionine breath tests for mitochondrial liver function assessment. 265
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 265
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 265
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 248
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 241
Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature 240
-Hepatic steatosis and vascular disease 238
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 237
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 230
134C-breath tests in the study of mitochondrial liver function 218
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 216
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 210
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 208
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 207
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 204
13C-breath tests in the study of microsomial liver function 204
recurrent acute hepatitis associated with use of cetrizine 195
13C-methionine breath tests for mitochondrial liver function assessment 194
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 192
Liver transplantation in patients with alcoholic liver disease: A retrospective study 191
Effect of sildenafil on diabetic gastropathy. 190
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 190
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 187
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 187
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 179
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 179
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 179
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 177
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 177
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 176
Potential use of liver function breath tests in the clinical practice. 176
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 175
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 174
Vanishing-recurrent benign liver lesions 174
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 167
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 167
13C-breath tests in the study of mitochondrial liver function 166
Cryoglobulinemia: a true internistic disease? 165
-Fatty liver and drugs 162
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 162
[The treatment of hepatocellular carcinoma: an update] 162
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 161
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 161
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 157
Faecal calprotectin concentrations in untreated coeliac patients 156
gastroesophageal reflux disease: facts and uncertaines 155
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 155
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 155
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 154
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 153
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 150
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 150
Severe giant cell arteritis associated with essential thrombocythaemia. 149
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 149
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 149
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 148
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 147
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 146
Tromboembolism and breast cancer: the hidden risk for patient and physician 146
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 146
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 145
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 145
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 144
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 144
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 143
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 143
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 141
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 141
-Nonalcoholic fatty liver disease: defining a common problem 140
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 139
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 137
Braised liver with herbs: the risks of naturopathic hepatoprotection. 137
Advanced colon cancer: staging and prognosis by CEA test 137
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 137
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 137
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 136
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 136
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 135
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 133
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 130
The role of elastography in non-Alcoholic fatty liver disease 130
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study 129
Alcoholic and nonalcoholic forms of fatty liver disease. 129
Gender affects 13C-ketoisocaproic acid breath test 128
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 125
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 125
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 125
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 125
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 124
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 123
Totale 17.097
Categoria #
all - tutte 122.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.759 69 162 46 177 124 43 29 288 62 89 320 350
2022/20233.745 493 492 290 543 284 450 163 341 432 51 152 54
2023/20241.879 120 560 77 89 80 272 119 64 23 76 162 237
2024/20253.887 100 108 335 121 305 146 88 213 608 402 776 685
2025/202610.320 1.537 309 673 1.110 1.732 636 1.801 490 703 707 357 265
2026/2027397 397 0 0 0 0 0 0 0 0 0 0 0
Totale 29.516